These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
187 related articles for article (PubMed ID: 26485568)
1. Chemotherapy-Related Amenorrhea and Menopause in Young Chinese Breast Cancer Patients: Analysis on Incidence, Risk Factors and Serum Hormone Profiles. Liem GS; Mo FK; Pang E; Suen JJ; Tang NL; Lee KM; Yip CH; Tam WH; Ng R; Koh J; Yip CC; Kong GW; Yeo W PLoS One; 2015; 10(10):e0140842. PubMed ID: 26485568 [TBL] [Abstract][Full Text] [Related]
2. Incidence of chemotherapy-induced ovarian failure in premenopausal women undergoing chemotherapy for breast cancer. Tiong V; Rozita AM; Taib NA; Yip CH; Ng CH World J Surg; 2014 Sep; 38(9):2288-96. PubMed ID: 24700093 [TBL] [Abstract][Full Text] [Related]
3. Profiles of lipids, blood pressure and weight changes among premenopausal Chinese breast cancer patients after adjuvant chemotherapy. Yeo W; Mo FKF; Pang E; Suen JJS; Koh J; Loong HHF; Yip CCH; Ng RYW; Yip CHW; Tang NLS; Liem GS BMC Womens Health; 2017 Jul; 17(1):55. PubMed ID: 28750616 [TBL] [Abstract][Full Text] [Related]
4. Assessment of ovarian function after chemotherapy in women with early and locally advanced breast cancer from Serbia. Malisic E; Susnjar S; Milovanovic J; Todorovic-Rakovic N; Kesic V Arch Gynecol Obstet; 2018 Feb; 297(2):495-503. PubMed ID: 29101609 [TBL] [Abstract][Full Text] [Related]
5. Impact of chemotherapy-induced amenorrhea in breast cancer patients: the evaluation of ovarian function by menstrual history and hormonal levels. Meng K; Tian W; Zhou M; Chen H; Deng Y World J Surg Oncol; 2013 May; 11():101. PubMed ID: 23688389 [TBL] [Abstract][Full Text] [Related]
6. Feature of amenorrhea in postoperative tamoxifen users with breast cancer. Kim H; Han W; Ku SY; Suh CS; Kim SH; Choi YM J Gynecol Oncol; 2017 Mar; 28(2):e10. PubMed ID: 27894163 [TBL] [Abstract][Full Text] [Related]
7. A pilot study of predictive markers of chemotherapy-related amenorrhea among premenopausal women with early stage breast cancer. Anders C; Marcom PK; Peterson B; Gu L; Unruhe S; Welch R; Lyons P; Behera M; Copland S; Kimmick G; Shaw H; Snyder S; Antenos M; Woodruff T; Blackwell K Cancer Invest; 2008; 26(3):286-95. PubMed ID: 18317970 [TBL] [Abstract][Full Text] [Related]
8. The risk of premature menopause induced by chemotherapy for early breast cancer. Lower EE; Blau R; Gazder P; Tummala R J Womens Health Gend Based Med; 1999 Sep; 8(7):949-54. PubMed ID: 10534297 [TBL] [Abstract][Full Text] [Related]
9. Incidence and predictors of ovarian function recovery (OFR) in breast cancer (BC) patients with chemotherapy-induced amenorrhea (CIA) who switched from tamoxifen to exemestane. Guerrero A; Gavilá J; Folkerd E; Ortiz B; Martínez F; García A; Climent MA; Guillem V; Ruíz A Ann Oncol; 2013 Mar; 24(3):674-9. PubMed ID: 23108951 [TBL] [Abstract][Full Text] [Related]
10. Menopausal symptoms in relationship to breast cancer-specific quality of life after adjuvant cytotoxic treatment in young breast cancer survivors. Yeo W; Pang E; Liem GS; Suen JJS; Ng RYW; Yip CCH; Li L; Yip CHW; Mo FKF Health Qual Life Outcomes; 2020 Feb; 18(1):24. PubMed ID: 32041627 [TBL] [Abstract][Full Text] [Related]
11. Antimullerian hormone and inhibin B are hormone measures of ovarian function in late reproductive-aged breast cancer survivors. Su HI; Sammel MD; Green J; Velders L; Stankiewicz C; Matro J; Freeman EW; Gracia CR; DeMichele A Cancer; 2010 Feb; 116(3):592-9. PubMed ID: 19918920 [TBL] [Abstract][Full Text] [Related]
12. Incidence and Predictive Factors for Recovery of Ovarian Function in Amenorrheic Women in Their 40s Treated With Letrozole. Krekow LK; Hellerstedt BA; Collea RP; Papish S; Diggikar SM; Resta R; Vukelja SJ; Holmes FA; Reddy PK; Asmar L; Wang Y; Fox PS; Peck SR; O'Shaughnessy J J Clin Oncol; 2016 May; 34(14):1594-600. PubMed ID: 26884554 [TBL] [Abstract][Full Text] [Related]
13. Changes in markers of ovarian reserve and endocrine function in young women with breast cancer undergoing adjuvant chemotherapy. Yu B; Douglas N; Ferin MJ; Nakhuda GS; Crew K; Lobo RA; Hershman DL Cancer; 2010 May; 116(9):2099-105. PubMed ID: 20187091 [TBL] [Abstract][Full Text] [Related]
14. Relationship between reproductive history, anthropometrics, lifestyle factors, and the likelihood of persistent chemotherapy-related amenorrhea in women with premenopausal breast cancer. Abusief ME; Missmer SA; Ginsburg ES; Weeks JC; Partridge AH Fertil Steril; 2012 Jan; 97(1):154-9. PubMed ID: 22192139 [TBL] [Abstract][Full Text] [Related]
15. Chemotherapy-induced amenorrhea, menopause-specific quality of life, and endocrine profiles in premenopausal women with breast cancer who received adjuvant anthracycline-based chemotherapy: a prospective cohort study. Yoo C; Yun MR; Ahn JH; Jung KH; Kim HJ; Kim JE; Park JY; Park KO; Yoon DH; Kim SB Cancer Chemother Pharmacol; 2013 Sep; 72(3):565-75. PubMed ID: 23842722 [TBL] [Abstract][Full Text] [Related]
16. Variation in endometrial thickening in women with amenorrhea on tamoxifen. Chang J; Powles TJ; Ashley SE; Iveson T; Gregory RK; Dowsett M Breast Cancer Res Treat; 1998 Mar; 48(1):81-5. PubMed ID: 9541192 [TBL] [Abstract][Full Text] [Related]
17. Undetectable antimüllerian hormone levels and recovery of chemotherapy-induced ovarian failure in women with breast cancer on an oral aromatase inhibitor. Dieudonné AS; Vandenberghe J; Geerts I; Billen J; Paridaens R; Wildiers H; Neven P Menopause; 2011 Jul; 18(7):821-4. PubMed ID: 21326118 [TBL] [Abstract][Full Text] [Related]
18. [Menstrual abnormality in patients with breast cancer receiving adjuvant endocrine-chemotherapy]. Yasumura T; Oka T; Honjo H; Okada H Gan To Kagaku Ryoho; 1988 Oct; 15(10):2947-52. PubMed ID: 3140733 [TBL] [Abstract][Full Text] [Related]
19. Chemotherapy-related amenorrhea in premenopausal women with breast cancer. Lee S; Kil WJ; Chun M; Jung YS; Kang SY; Kang SH; Oh YT Menopause; 2009; 16(1):98-103. PubMed ID: 18849877 [TBL] [Abstract][Full Text] [Related]
20. Endocrine status of premenopausal node-positive breast cancer patients following adjuvant chemotherapy and long-term tamoxifen. Ravdin PM; Fritz NF; Tormey DC; Jordan VC Cancer Res; 1988 Feb; 48(4):1026-9. PubMed ID: 3123050 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]